mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes.

Cell Rep Med · 2022 · PMC9179023 · PMID 35688161

Europe PMC DOI

hedged sentence

0.9000

closest p · 18.0× alpha

0.9000

boldest claim

The sentences

did not reach statistical significancep > 0.9not close (p > 0.1)

Although the anti-spike and RBD titers after boosting trended higher than those obtained 14 days after the primary two-dose immunization series, these differences did not reach statistical significance (p > 0.9).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.